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Abstract
This paper presents a literature review on right heart endocarditis in patients with a perma-
nent pacemaker (PM) or implantable cardioverter-defibrillator (ICD). We postulate putting
a great deal more emphasis on separation of lead-dependent infective endocarditis from other
types of infective endocarditis. We stress the need for screening patients with PM/ICD and
pulmonary signs using transesophageal echocardiography. Antibiotic therapy and PM/ICD
removal is the treatment of choice in such patients. (Cardiol J 2010; 17, 2: 205–210)
Key words: right heart endocarditis, pacemaker, implantable cardioverter-
-defibrillator, percutaneous lead extraction
Introduction
The first reports on infective complications
after permanent endocardial stimulation were pub-
lished in the 1960s. The symptoms of infection were
described as ‘sepsis’, i.e. the body’s response to
infection. The term ‘sepsis’ had at that time a dif-
ferent meaning (according to [1]). It comprised in-
fections in the pacemaker pocket. Positive blood
culture tests served as the basis for diagnosing gen-
eral infection described as septicemia. Its main
symptom was infection in the pacemaker genera-
tor pocket involving various sites of the abdomen
and thorax that were used at that time. The infec-
tion affected also neck regions due to lead introduc-
tion sites into the venous system. The association
of the infective endocarditis with any local symp-
toms along the passage of the lead from the en-
trance in the vein to the pacemaker pocket toge-
ther with positive blood culture tests was deduced
from later diagnosis established during cardiac sur-
gery or post mortem examination.
These first publications referred to the classic
picture of infective endocarditis described by Os-
ler in 1885 [2]. Osler, being both a clinician and
anatomopathologist, joined the previously observed
symptoms in patients with the autopsy picture of
their hearts and vessels. Since his publications it
has been known that infective endocarditis is a dis-
ease of heart structures and great vessels, toge-
ther with systemic symptoms. The introduction of
echocardiography into clinical practice represents
a diagnostic revolution that made the non-invasive
discovery of indisputable disease symptoms in liv-
ing patients possible. Only then were the elements
justifying the diagnosis of infective endocarditis
with the possibility of visualizing vegetations  de-
fined precisely, which was taken into consideration
in the Duke criteria [3]. As it noted before, a huge
group of patients with cardiac implants (a group
exceptionally exposed to infective endocarditis) was
added to the original Osler’s description.
Apart from artificial valves and vascular pros-
theses, other cardiac devices to steer the heart rate
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such as pacemakers (PM) and implantable cardio-
verter-defibrillators (ICD) came into use. By 2008,
endocardial leads for heart pacing had a history of
50 years. The widespread implantation of cardiac
devices had resulted in 3.25 million functioning PM
and 180,000 ICD across the world [4]. At the same
time, progress in contemporary cardiology, including
treatment of heart rhythm disturbances, resulted in
a significantly prolonged lifespan for people with chronic
cardiac diseases. Patients with cardiac devices under-
go repeated exchanges of their PM/ICDs over the
course of their increasingly long lifetimes. For that very
reason, they are especially exposed to post-operative
infective complications of the pockets, as well as the
development of infective endocarditis related to the
presence of the leads in their right heart chambers.
Pacemaker related infections
The rate of PM/ICD infections has been shown
to increase by 124% within the last decade [5].
The classification of infections related to car-
diac devices was proposed many years ago. Charles
Byrd divided pacemaker-related infections into the
following groups [6]:
— endocarditis;
— inflammation of myocardial tissue;
— infected vegetations;
— infected implanted foreign bodies;
— bacteremia without signs of endocarditis;
— local infections of subcutaneous tissue;
— chronic infections limited to the pocket area;
— superinfection of pacemaker pocket area;
— chronic pocket infection with granulation tissue.
Recent papers on PM/ICD-dependent infec-
tions appear to underestimate the distinctive role
of right heart endocarditis as one of the most im-
portant infectious complications [7, 8].
Lead-dependent infective endocarditis
We can ask the question: is there a need to pay
a closer look at a specific type of infective endocarditis
caused by endocardial leads, which, despite being pre-
viously described, have been under-recognized so far?
We suggest giving it a name: LDIE (lead-de-
pendent infective endocarditis), which may attract
the attention of physicians to infective diseases in
connection with endocardial leads. The positive
answer is based on some facts related to the spe-
cific nature of the disease:
1. LDIE is the changes in the chambers and tissues
of the right heart as well as in the veins introdu-
cing leads to the heart and arteries leading blood
from the heart to the pulmonary circulation with
the presence of one or more endocardial leads.
2. The symptoms of LDIE imitate pulmonary
diseases.
3. Staphylococci are of special importance among
pathogens.
4. For effective treatment of LDIE, it is necessa-
ry to remove the whole system i.e. PM/ICD
with leads, independently of the chosen anti-
biotic therapy.
A specific feature of the disease is difficulty in
its diagnosis due to the advanced age of the patients.
This disease entity is not present in the cardiology
textbooks despite the fact that it is rapidly increas-
ing as a clinical and therapeutic problem. It is pre-
sented in case reports or retrospective analyses of
small groups of patients (from less than ten to a few
dozen patients) [7, 9–12]. First reports of  bacterial
right heart endocarditis appeared in the second half
of the 20th century. Initially, the problem was only
noticed in drug addicts and as a iatrogenic compli-
cation in patients with catheters in their right heart
chambers or in association with prolonged hospi-
talization [7]. Right heart endocarditis in patients
with permanent PM and ICD has also been report-
ed [7, 9–12]. The reported rate of infection connect-
ed with a PM/ICD system ranges from 0.13% to
19.9%, and from 0.7% to 1.2% for LDIE.
Etiology of LDIE
From the pathomorphological viewpoint, right
heart endocarditis is characterized by vegetations
in the echocardiographic images — the fragile wart-
like structures which are accumulations of micro-
organisms, thrombocytes, fibrin and inflammatory
cells. In the antegrade flow vegetations can only
migrate to pulmonary circulation, thus resulting in
pulmonary embolism [7, 10–12].
The pathogenesis of vegetations on endocar-
dial leads and/or right heart endocardium is unclear
and deduced from the following hypotheses [6]:
1. Some breeds of bacteria, especially staphylococ-
ci, and perhaps other gram-position organisms,
produce adhesins, thanks to which bacterial colo-
nies can adhere to every smooth surface of a car-
diac implant and create a biofilm to protect them
from the host’s immune system and antibiotic the-
rapy. Also the formation of clots due to slow blo-
od flow around the electrodes and turbulences
caused by the presence of the electrodes may re-
sult in bacteria growth because the blood clots may
then be colonized by bacteria appearing in the blo-
odstream during transient bacteremia related to
personal hygiene (teeth brushing and gingival
microinjuries) or therapeutic procedures (dental,
urological, gynecological, etc.).
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2. Localized infection of the PM/ICD pocket via
the electrodes and vessels and the formation
of vegetations as a result of the activation of
the immune and coagulation system by bacte-
rial colonies.
The new phenomenon i.e. endocardial lead
abrasion, published recently by our group is com-
plementary both to the first and second concept of
vegetation formation and accounts for the failure of
antibiotic therapy in LDIE without prior removal of
old and abraded electrodes [13]. We describe two
cases of LDIE which display the complexity of the
disease, its probable etiology and results after com-
plete removal of all endocardial leads.
Case 1
A 72 year old man has been suffering from re-
current fever of three months’ duration despite re-
peated antibiotic therapy combined with periods of
hospitalization. Initially, lab tests revealed only
C-reactive protein (CRP) level to be elevated, and
transesophageal echocardiography (TEE) suspect-
ed vegetations being associated with right atrium
leads. Only the Staphylococcus epidermidis, con-
firmed by blood culture tests, and pulmonary em-
bolism, confirmed in computed tomography, deter-
mined us to remove the leads. The patient’s stimu-
lation system consisted of one atrio-ventricular
(AV) lead and two additional leads. The AV lead was
implanted 11 years previously due to the AV block
— a complication after aortic artificial valve implan-
tation, whereas two additional leads were installed
nine years later, during planned pacemaker ex-
change with coexisting indications for resynchro-
nization stimulation. Both new leads, the atrial and
the left-ventricle one, were placed in the coronary
sinus (Fig. 1A). After the removal of the stimula-
tion system, we discovered the endocardial abra-
sion of silicone insulation of the 11 year-old AV lead
Figure 1. A. Fluoroscopy before the stimulation system removal. The contact place of leads in the right atrium is in
the circle. There are two leads visible: the 11 year old VDD lead (Biotronik SL 60/13 BP), a two year old lead, active
fixation in the coronary sinus outlet track (Biotronik Selox BP), and two year old left-ventricle lead (Biotronik Corox
UP); B, C. Perioperative picture of removed endocardial leads. The arrows show the site of abrasion of a silicone
insulation of the 11 year old lead with a typical thinning of the insulation close to tearing and discoloration of the
metal wire inside the lead.
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at the contact place with other leads on the right
atrium level (Fig. 1B, C). After recovery from LDIE,
a new pacing system was implanted from the access
on another side of the thorax.
Case 2
In a 65-year old man with a seven year-old AV
two-lead pacing system, we decided to remove the
system despite the negative blood culture tests and
no changes in the stimulation pocket. Diagnosis of
LDIE was based on a recurrent fever of six months’
duration and on the presence of 1cm vegetations in
the right atrium and right ventricle, both being in
connection with the leads. The X-ray scan of the
thorax, apart from the limited concentration of pul-
monary tissue in the upper and middle lobe, re-
vealed the leads being too long in the heart and the
lead loop in the right ventricle (Fig. 2A). Such a si-
tuation is caused by the lack of efficient fixation of
leads in the stimulation pocket during the proce-
dure of stimulation system implantation. On at-
tempting to insert the fixing stylet into the leads,
pus came out of the atrial lead. The pus contained
Staphylococcus aureus which was proved in later
examination (Fig. 2B). The removed atrial lead re-
vealed endocardial abrasions of its silicone insula-
tion in several sites. Abrasion sites were connect-
ed with mutual contact places of looped leads, seen
before in fluoroscopy (Fig. 2A, arrows). The remov-
al of the stimulation system resulted in the subsid-
ence of the recurrent fever.
The risk factors of an infection associated with
PM/ICD systems include fever 24 hours before
implantation, temporary stimulation prior to perma-
nent, repeat procedure i.e. exchange/revision of the
device, early repair, and lastly the lack of antibiotic
prophylaxis before device implantation [9].
Despite the widely-accepted hypotheses of
PM/ICD pocket infections, including the most
dangerous LDIE, the presence of the pacema-
ker/cardioverter system together with endocardial
leads is not considered as an indication for anti-
biotic prophylaxis when a high risk procedure is
performed [14].
Symptoms of LDIE
The classical symptoms of LDIE are [10–12, 15]:
— local PM/ICD pocket infection (with varying
percentage of occurrence);
— pulmonary symptoms: cough and pain in the
thoracic cavity, pleural in character, dyspnoea,
symptoms of pneumonia, atypical X-ray chan-
ges in the lungs suggesting pulmonary embo-
lism caused by infected vegetations (26–41%);
— severe systemic inflammation: persistent fever
(80%), shivers (75%), weakness, fatigue
(75%), anorexia (36%), excessive perspiration
(32%), pale, ‘café au lait’, sallow complexion
(late stage);
— lab test signs of LDIE such as: positive blood
cultures (80%), anemia (66%), leukocytosis
(59%), high erythrocyte sedimentation rate,
CRP (59%), erythrocyturia and albuminuria are
unspecific signs of the disease. These symp-
toms are presented in Table 1.
This particular disease lacks the typical symp-
toms of minor Duke criteria, i.e. the symptoms of
embolism in systemic circulation caused by left
heart vegetations. Vegetations and emboli are still
present in the pulmonary circulation, however. Due
to the instability of many symptoms, this disease is
Figure 2. A. Fluoroscopy before the stimulation system removal: the atrial lead, Biotronik YP BP active, implanted to
the coronary sinus outflow track and the ventricular lead, Biotronik Synox BP, implanted to the right ventricle apex.
Arrows show the mutual dynamic contact of leads’ loops resulting from the leads being too long; B, C. Perioperative
pictures; B — pus outflow from the atrial lead, C — multiple abrasions of a silicone insulation of the atrial lead,
Biotronik YP BP, with exposition of the metal wire and its discoloration.
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usually diagnosed at a late stage, or remains unre-
cognized until the patient’s death.
Patients with LDIE are often referred for pul-
monary, internal or even oncological diagnostics
because of atypical X-ray changes. Such changes
may temporarily subside after antibiotic therapy,
but almost invariably recur. Echocardiographic dis-
appearance of vegetations is not synonymous with
recovery if the leads are still in the heart chambers.
This results in a totally different clinical picture, but
the key point of the diagnostic procedure should be
special attention to the cardiac implant (endocardial
leads) in the right heart. The association between
right heart vegetations and the endocardial leads is
the basis for the diagnosis of this disease. Our ex-
perience shows that the individual course of LDIE
varies. We have established a registry of about
300 patients who underwent percutaneous removal
of the leads. Our observations revealed LDIE in al-
most 20% of patients qualified for endocardial lead
removal [16]. A preliminary review of the registry
was published in 2009 [17].
Treatment of LDIE
We believe that patients with PM/ICDs sus-
pected of LDIE should be hospitalized in an elec-
trotherapy center.  The patient’s blood culture tests
as well as tests of the skin, nose, pharynx or from
the incompletely healed wound or a fistula to the
PM/ICD pocket, should be made. At the time of the
PM/ICD system removal, blood culture samples
should also be taken from the PM/ICD pocket inci-
sion site and from every removed lead. A febrile
patient should be given antibiotics according to the
results of blood culture tests, and vancomycin in the
case of a negative test.
It should be underlined that echocardiography,
including TEE, must be a basic diagnostic proce-
dure. The course of treatment in a case of LDIE
can be monitored using this particular diagnostic
method.
In patients with pulmonary embolism caused
by vegetations migrated from the right heart cham-
bers, lung scintigraphy and computed tomography
are valuable imaging tools. Unfortunately, the pres-
ence of leads in the right heart chambers is not con-
sidered as a risk factor of pulmonary embolism or an
indication for antithrombolitic prophylaxis [18, 19].
After confirming the diagnosis, an initial deci-
sion to remove the whole system as well as the
choice of technique (percutaneous or surgical)
should be made. There should be no doubts wheth-
er to remove the system or adopt a ‘conservative’
approach. LDIE has already been a class 1 indica-
tion for removal of the whole lead and PM/ICD sys-
tem for nine years [20, 21]. Mortality in cases of
LDIE treated only with antibiotics is 66% compared
to a three times lower percentage in cases of the-
rapy combining antibiotics and the complete removal
of the cardiac implant [6, 7].
The procedure of percutaneous lead removal
carries a risk of 1–2%. Cardio-pulmonary bypass
surgery carries a 10% risk of perioperative morta-
lity, and it is a much more serious strain for the pa-
tient [22].
It should be emphasized that nowadays there
are only four indications for cardiac surgery:
— the need for heart valve repair;
— ‘giant vegetation’ in the chambers of the right
heart (vegetation of 2.5 cm on echocardiogra-
phy);
— failure of percutaneous removal;
— complications after percutaneous removal.
An additional advantage of cardiac surgery un-
der the above circumstances is the chance to im-
plant the epicardial leads, whereas placing endocar-
dial leads in the setting of persistent bacteremia or
residual infected vegetation may be problematic and
Table 1. Symptoms of lead-dependend infective endocarditis.
Year Author No. of Pocket Fever Results of blood
patients infection culture tests
2008 Sohail MR, 44 80% 80% Positive blood culture 77%
Mayo Clinic [10] Staphylococcus coagulation negative 41%
Aureus 41%
2008 Greenspon AJ, 51 22% 51% Positive blood culture 92%
Philadelphia [11] Staphylococcus coagulation negative 22%
Aureus 53%
2007 Massoure P-L, 60 35% 78% Positive blood culture 68%
Bordeaux FR [12] Staphylococcus epidermidis 68%
Aureus 17%
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may need to be delayed substantially. In pacema-
ker-dependent patients, in case of percutaneous re-
movals, only temporary stimulation can be used,
until the end of antibiotic therapy course and recov-
ery from endocarditis.
A cardiac surgeon with special training and
experience in lead extraction procedures, together
with an anesthesiologist, comprise a team to secure
percutaneous lead removal and to intervene imme-
diately if complications occur.
A higher safety level of percutaneous PM/ICD
system removal compared with cardiac surgery has
resulted in expanding the indications for percuta-
neous procedures.
Conclusions
1. LDIE of the right heart in PM/ICD patients
often goes undiagnosed.
2. Every PM/ICD patient with pulmonary symp-
toms should be screened for right heart LDIE
and pulmonary embolism.
3. PM/ICD patients with known LDIE of the ri-
ght heart should be given antibiotics and un-
dergo removal of the stimulation system.
4. Percutaneous removal of the stimulation sys-
tem is a safer and less invasive therapeutic
approach than cardiac surgery.
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